Spain braces itself for early devolution
This article was originally published in Clinica
Spain's medical devices industry has not welcomed the government's recent decision to complete devolution of healthcare early in 2002. It fears that a hastening of the process, which had been due for completion no earlier than 2003, can only exacerbate any difficulties experienced by the regions that have undergone the process so far.
You may also be interested in...
The Swiss giant is hoping to get seven more approvals for its blockbuster immunology drug over the next 10 years.
Cadila has filed for approval of saroglitazar for NASH in India. The drug, which could emerge as the first medicine for the indication if approved, is already being used by a million Indian patients for diabetic dyslipidemia and hypertriglyceridemia.
It has been a long and sometimes tortuous development path for Lupuzor but ImmuPharma's chief executive tells Scrip the company's faith in the lupus drug is bearing fruit.